AGA Medical Corporation Product Pipeline Analysis

SUMMARY

AGA Medical Corporation Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a AGA Medical Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Company Overview 8
2.1 Key Information 8
2.2 Industry Outlook -- Cardiovascular Devices 8
3 Major Products and Services 9
3.1 Overview 9
4 Competitors 10
5 Key Employees 11
6 Locations And Subsidiaries 12
6.1 Head Office 12
7 Recent Developments 13
7.1 Corporate Communications 13
7.1.1 Jun 20, 2008: AGA Medical Announces Management Changes 13
7.1.2 Jun 11, 2007: AGA Appoints New CLO 13
7.1.3 Mar 05, 2007: AGA Appoints VP, Worldwide Sales And Marketing 14
7.1.4 Oct 02, 2006: AGA Appoints New CFO 14
7.2 Legal and Regulatory 15
7.2.1 Jun 03, 2008: AGA Agrees To Pay $2 Million Civil Penalty 15
7.2.2 Jul 31, 2007: AGA Wins Patent Infringement Lawsuit Against Occlutech 15
7.3 Product News 16
7.3.1 May 16, 2008: AGA Medical Corporation Receives CE Mark Approval For The AMPLATZER Vascular Plug III 16
7.3.2 Feb 12, 2008: AGA Medical Corporation Receives European CE Mark Approval For The AMPLATZER Duct Occluder II 16
7.3.3 Sep 10, 2007: AGA Medical Corporation Receives Approval For The AMPLATZER Muscular Ventricular Septal Defect Occluder 16
7.3.4 Aug 24, 2007: AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II 17
7.3.5 Jul 21, 2006: AGA Medical Announces Enrollment Of First Patients In US Migraine Study 17
7.4 Product Approvals 17
7.4.1 May 16, 2008: AGA Medical Corporation Receives CE Mark Approval For The AMPLATZER Vascular Plug III 17
7.4.2 Feb 12, 2008: AGA Medical Corporation Receives European CE Mark Approval For The AMPLATZER Duct Occluder II 18
7.4.3 Sep 10, 2007: AGA Medical Corporation Receives Approval For The AMPLATZER Muscular Ventricular Septal Defect Occluder 18
7.4.4 Aug 24, 2007: AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II 18
7.5 Clinical Trials 19
7.5.1 Jul 21, 2006: AGA Medical Announces Enrollment Of First Patients In US Migraine Study 19
8 AGA Medical Corporation Pipeline Products 20
8.1 AGA Medical Corporation Product Pipeline Analysis 20
8.1.1 AGA Medical Corporation Pipeline Products By Equipment Type 20
8.1.2 AGA Medical Corporation Pipeline Products By Development Stage 21
8.1.3 AGA Medical Corporation Pipeline Products By Therapy Area 21
8.1.4 AGA Medical Corporation Pipeline Products By Clinical Trials 22
8.1.5 AGA Medical Corporation Pipeline Products By News Summary 22
8.2 AMPLATZER Duct Occluder II 22
8.2.1 Product Description 22
8.2.2 Product Status 22
8.2.3 Clinical Trials 23
8.2.4 Product Milestone 24
8.3 AMPLATZER Vascular Plug III 24
8.3.1 Product Description 24
8.3.2 Product Status 25
8.3.3 Product Milestone 25
8.4 AMPLATZER PFO Occluder-Cryptogenic strokes 26
8.4.1 Product Description 26
8.4.2 Product Status 26
8.4.3 Clinical Trials 26
8.5 AMPLATZER PFO Occluder-migraine 27
8.5.1 Product Description 27
8.5.2 Product Status 27
8.5.3 Product Patent Details 27
9 Appendix 29
9.1 Methodology 29
9.1.1 Coverage 29
9.1.2 Secondary Research 30
9.1.3 Primary Research 30
9.1.4 Expert Panel Validation 31
9.2 Contact Us 31
9.3 About Global Markets Direct 31
9.4 Disclaimer 31

1.1 List of Tables
Table 1: AGA Medical Corporation,Key Facts 8
Table 2: AGA Medical Corporation, Key Employees, 11
Table 3: AGA Medical Corporation Pipeline Products by Equipment Type 20
Table 4: AGA Medical Corporation Pipeline Products By Development Stage 21
Table 5: AGA Medical Corporation Pipeline Products By Therapy Area 21
Table 6: AGA Medical Corporation Pipeline Products By Clinical Trials 22
Table 7: AGA Medical Corporation Pipeline Products By News Summaries 22

1.2 List of Figures
Figure 1: AGA Medical Corporation Pipeline Products By Development Stage 21
Figure 2: Global Markets Direct Methodology 29